Hims & Hers Health (HIMS) Investors Have Opportunity to Lead Securities Fraud Lawsuit
Rosen Law Firm is notifying purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) securities of their opportunity to lead a potential securities fraud lawsuit. The deadline to act is November 2, 2026.
Business Area: Technology
Company: Hims & Hers Health, Inc.
Rosen Law Firm, a global investor rights law firm, has alerted purchasers of Hims & Hers Health, Inc. (NYSE: HIMS) securities to their opportunity to lead a potential securities fraud class action lawsuit.
The lawsuit targets securities purchased between August 4, 2025, and July 29, 2026, inclusive. Rosen Law Firm is urging any investors who acquired HIMS stock during this period to contact them by November 2, 2026.
The suit alleges that Hims & Hers Health likely made materially misleading statements regarding its business operations and future prospects. Investors claim they suffered financial losses as a result of these alleged misrepresentations.
Rosen Law Firm focuses on class action and securities litigation. The firm has encouraged all potentially affected shareholders to reach out for further details and to discuss their legal options.